Han Wook Choi's most recent trade in Vor Biopharma Inc was a trade of 2,061 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc | Han Wook Choi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 01 May 2025 | 2,061 | 51,280 | - | 0.7 | 1,360 | Common Stock |
| Vor Biopharma Inc | Han Wook Choi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 315,000 | 315,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Han Wook Choi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 52,500 | 52,500 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Han Wook Choi | Chief Financial Officer | 30 Sep 2024 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) |